TG Therapeutics Inc (TGTX)
30.84
-4.06
(-11.62%)
USD |
NASDAQ |
Nov 14, 16:00
31.00
+0.16
(+0.50%)
After-Hours: 20:00
TG Therapeutics Cash from Operations (Quarterly): -12.20M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -12.20M |
| June 30, 2024 | 5.536M |
| March 31, 2024 | -8.207M |
| December 31, 2023 | -13.21M |
| September 30, 2023 | 83.70M |
| June 30, 2023 | -42.00M |
| March 31, 2023 | -59.90M |
| December 31, 2022 | -23.87M |
| September 30, 2022 | -34.50M |
| June 30, 2022 | -49.12M |
| March 31, 2022 | -68.69M |
| December 31, 2021 | -86.91M |
| September 30, 2021 | -67.20M |
| June 30, 2021 | -60.17M |
| March 31, 2021 | -81.36M |
| December 31, 2020 | -52.03M |
| September 30, 2020 | -56.53M |
| June 30, 2020 | -43.83M |
| March 31, 2020 | -62.12M |
| December 31, 2019 | -30.39M |
| September 30, 2019 | -33.20M |
| June 30, 2019 | -35.86M |
| March 31, 2019 | -33.35M |
| December 31, 2018 | -33.69M |
| September 30, 2018 | -33.01M |
| Date | Value |
|---|---|
| June 30, 2018 | -34.18M |
| March 31, 2018 | -28.04M |
| December 31, 2017 | -21.86M |
| September 30, 2017 | -22.78M |
| June 30, 2017 | -26.83M |
| March 31, 2017 | -22.30M |
| December 31, 2016 | -17.02M |
| September 30, 2016 | -15.04M |
| June 30, 2016 | -12.85M |
| March 31, 2016 | -16.67M |
| December 31, 2015 | -12.90M |
| September 30, 2015 | -10.66M |
| June 30, 2015 | -12.25M |
| March 31, 2015 | -8.882M |
| December 31, 2014 | -15.11M |
| September 30, 2014 | -8.051M |
| June 30, 2014 | -3.573M |
| March 31, 2014 | -8.329M |
| December 31, 2013 | -4.824M |
| September 30, 2013 | -1.154M |
| June 30, 2013 | -2.556M |
| March 31, 2013 | -2.205M |
| December 31, 2012 | -0.8333M |
| September 30, 2012 | -2.993M |
| June 30, 2012 | -0.4998M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-86.91M
Minimum
Dec 2021
83.70M
Maximum
Sep 2023
-38.15M
Average
-46.48M
Median
Cash from Operations (Quarterly) Benchmarks
| ADMA Biologics Inc | 25.03M |
| Varex Imaging Corp | 8.00M |
| Rhythm Pharmaceuticals Inc | -25.22M |
| Inspire Medical Systems Inc | 52.28M |
| Precision BioSciences Inc | -5.912M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.334M |
| Cash from Financing (Quarterly) | 134.45M |
| Free Cash Flow | -28.11M |
| Free Cash Flow Per Share (Quarterly) | -0.0761 |
| Free Cash Flow to Equity (Quarterly) | -153.85M |
| Free Cash Flow to Firm (Quarterly) | -2.382M |
| Free Cash Flow Yield | -0.59% |